Gene · 3595
Papers1,950
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 1,950
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Human IL-23 is essential for IFN-γ-dependent immunity to mycobacteria. | Sci Immunol | 2023 | 36763636 | PubTator, text mining | PubMed |
| Elevated ADAM-like Decysin-1 (ADAMDEC1) expression is associated with increased chemo-sensitivity and improved prognosis in breast cancer patients. | Ann Transl Med | 2023 | 36760254 | PubTator, text mining | PubMed |
| Liver immunity, autoimmunity, and inborn errors of immunity. | World J Hepatol | 2023 | 36744162 | PubTator, text mining | PubMed |
| Disseminated multidrug-resistant tuberculosis and SARS-CoV-2 co-infection in a child with IL-12Rβ1 deficiency. | Indian J Tuberc | 2023 | 36740310 | PubTator, text mining | PubMed |
| Integrated analysis of ATAC-seq and RNA-seq reveals the transcriptional regulation network in SLE. | Int Immunopharmacol | 2023 | 36738683 | PubTator, text mining | PubMed |
| Human IRF1 governs macrophagic IFN-γ immunity to mycobacteria. | Cell | 2023 | 36736301 | PubTator, text mining | PubMed |
| Gene-environment interactions in birth defect etiology: Challenges and opportunities. | Curr Top Dev Biol | 2023 | 36707208 | PubTator, text mining | PubMed |
| Predictive biomarkers for the responsiveness of recurrent glioblastomas to activated killer cell immunotherapy. | Cell Biosci | 2023 | 36694264 | PubTator, text mining | PubMed |
| Single-nucleus RNA sequencing and deep tissue proteomics reveal distinct tumour microenvironment in stage-I and II cervical cancer. | J Exp Clin Cancer Res | 2023 | 36683048 | PubTator, text mining | PubMed |
| Network-Based Assessment of Minimal Change Disease Identifies Glomerular Response to IL-7 and IL-12 Pathways Activation as Innovative Treatment Target. | Biomedicines | 2023 | 36672735 | PubTator, text mining | PubMed |
| Transcriptome analysis reveals the differential inflammatory effects between propofol and sevoflurane during lung cancer resection: a randomized pilot study. | World J Surg Oncol | 2023 | 36647133 | PubTator, text mining | PubMed |
| Mendelian Susceptibility to Mycobacterial Disease (MSMD): Clinical, Immunological, and Genetic Features of 22 Patients from 15 Moroccan Kindreds. | J Clin Immunol | 2023 | 36630059 | PubTator, text mining | PubMed |
| IL-10-producing Th1 cells possess a distinct molecular signature in malaria | J Clin Invest | 2023 | 36594463 | PubTator, text mining | PubMed |
| The Absence of IL-12Rβ2 Expression on Recipient Nonhematopoietic Cells Diminishes Acute Graft-versus-Host Disease in the Gastrointestinal Tract. | J Immunol | 2023 | 36548465 | PubTator, text mining | PubMed |
| High expression of caspase-8 as a predictive factor of poor prognosis in patients with esophageal cancer. | Cancer Med | 2023 | 36533709 | PubTator, text mining | PubMed |
| Immune biology of NSCLC revealed by single-cell technologies: implications for the development of biomarkers in patients treated with immunotherapy. | Semin Immunopathol | 2023 | 36414693 | PubTator, text mining | PubMed |
| Association between gene polymorphisms of IL-12, IL-12 receptor and IL-27 and organ involvement in Iranian endometriosis patients. | Int J Immunogenet | 2023 | 36328955 | PubTator, text mining | PubMed |
| Inherited human ITK deficiency impairs IFN-γ immunity and underlies tuberculosis. | J Exp Med | 2023 | 36326697 | PubTator, text mining | PubMed |
| Reduced circulating interleukin 35 is associated with enhanced peripheral T cell function in primary biliary cholangitis. | Biomol Biomed | 2023 | 36314719 | PubTator, text mining | PubMed |
| Emerging principles of cytokine pharmacology and therapeutics. | Nat Rev Drug Discov | 2023 | 36131080 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3595/papers?page=10